On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts

Sara Iachettini, Malcolm F G Stevens, Mark Frigerio, Marc G. Hummersone, Ian Hutchinson, Thomas P. Garner, Mark S. Searle, David W. Wilson, Manoj Munde, Rupesh Nanjunda, Carmen D'Angelo, Pasquale Zizza, Angela Rizzo, Chiara Cingolani, Federica De Cicco, Manuela Porru, Maurizio D'Incalci, Carlo Leonetti, Annamaria Biroccio, Erica Salvati

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Quadruplexes DNA are present in telomeric DNA as well as in several cancer-related gene promoters and hence affect gene expression and subsequent biological processes. The conformations of G4 provide selective recognition sites for small molecules and thus these structures have become important drug-design targets for cancer treatment. The DNA G-quadruplex binding pentacyclic acridinium salt RHPS4 (1) has many pharmacological attributes of an ideal telomere-targeting agent but has undesirable off-target liabilities. Notably a cardiovascular effect was evident in a guinea pig model, manifested by a marked and sustained increase in QTcB interval. In accordance with this, significant interaction with the human recombinant β2 adrenergic receptor, and M1, M2 and M3 muscarinic receptors was observed, together with a high inhibition of the hERG tail current tested in a patch clamp assay. Two related pentacyclic structures, the acetylamines (2) and (3), both show a modest interaction with β2 adrenergic receptor, and do not significatively inhibit the hERG tail current while demonstrating potent telomere on-target properties comparing closely with 1. Of the two isomers, the 2-acetyl-aminopentacycle (2) more closely mimics the overall biological profile of 1 and this information will be used to guide further synthetic efforts to identify novel variants of this chemotype, to maximize on-target and minimize off-target activities. Consequently, the improvement of toxicological profile of these compounds could therefore lead to the obtainment of suitable molecules for clinical development offering new pharmacological strategies in cancer treatment.

Original languageEnglish
Article number68
JournalJournal of Experimental and Clinical Cancer Research
Volume32
Issue number1
DOIs
Publication statusPublished - 2013

Fingerprint

G-Quadruplexes
Telomere
Adrenergic Receptors
Tail
Salts
Muscarinic M3 Receptors
Muscarinic M2 Receptors
Pharmacology
Muscarinic M1 Receptors
Ligands
Biological Phenomena
Neoplasm Genes
Drug Design
Toxicology
Neoplasms
Guinea Pigs
Gene Expression
DNA

Keywords

  • Anti-cancer therapy
  • G-quadruplex
  • Telomere targeting agents

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts. / Iachettini, Sara; Stevens, Malcolm F G; Frigerio, Mark; Hummersone, Marc G.; Hutchinson, Ian; Garner, Thomas P.; Searle, Mark S.; Wilson, David W.; Munde, Manoj; Nanjunda, Rupesh; D'Angelo, Carmen; Zizza, Pasquale; Rizzo, Angela; Cingolani, Chiara; De Cicco, Federica; Porru, Manuela; D'Incalci, Maurizio; Leonetti, Carlo; Biroccio, Annamaria; Salvati, Erica.

In: Journal of Experimental and Clinical Cancer Research, Vol. 32, No. 1, 68, 2013.

Research output: Contribution to journalArticle

Iachettini, S, Stevens, MFG, Frigerio, M, Hummersone, MG, Hutchinson, I, Garner, TP, Searle, MS, Wilson, DW, Munde, M, Nanjunda, R, D'Angelo, C, Zizza, P, Rizzo, A, Cingolani, C, De Cicco, F, Porru, M, D'Incalci, M, Leonetti, C, Biroccio, A & Salvati, E 2013, 'On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts', Journal of Experimental and Clinical Cancer Research, vol. 32, no. 1, 68. https://doi.org/10.1186/1756-9966-32-68
Iachettini, Sara ; Stevens, Malcolm F G ; Frigerio, Mark ; Hummersone, Marc G. ; Hutchinson, Ian ; Garner, Thomas P. ; Searle, Mark S. ; Wilson, David W. ; Munde, Manoj ; Nanjunda, Rupesh ; D'Angelo, Carmen ; Zizza, Pasquale ; Rizzo, Angela ; Cingolani, Chiara ; De Cicco, Federica ; Porru, Manuela ; D'Incalci, Maurizio ; Leonetti, Carlo ; Biroccio, Annamaria ; Salvati, Erica. / On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts. In: Journal of Experimental and Clinical Cancer Research. 2013 ; Vol. 32, No. 1.
@article{e894617d42e745ab95cc9d25fa79572c,
title = "On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts",
abstract = "Quadruplexes DNA are present in telomeric DNA as well as in several cancer-related gene promoters and hence affect gene expression and subsequent biological processes. The conformations of G4 provide selective recognition sites for small molecules and thus these structures have become important drug-design targets for cancer treatment. The DNA G-quadruplex binding pentacyclic acridinium salt RHPS4 (1) has many pharmacological attributes of an ideal telomere-targeting agent but has undesirable off-target liabilities. Notably a cardiovascular effect was evident in a guinea pig model, manifested by a marked and sustained increase in QTcB interval. In accordance with this, significant interaction with the human recombinant β2 adrenergic receptor, and M1, M2 and M3 muscarinic receptors was observed, together with a high inhibition of the hERG tail current tested in a patch clamp assay. Two related pentacyclic structures, the acetylamines (2) and (3), both show a modest interaction with β2 adrenergic receptor, and do not significatively inhibit the hERG tail current while demonstrating potent telomere on-target properties comparing closely with 1. Of the two isomers, the 2-acetyl-aminopentacycle (2) more closely mimics the overall biological profile of 1 and this information will be used to guide further synthetic efforts to identify novel variants of this chemotype, to maximize on-target and minimize off-target activities. Consequently, the improvement of toxicological profile of these compounds could therefore lead to the obtainment of suitable molecules for clinical development offering new pharmacological strategies in cancer treatment.",
keywords = "Anti-cancer therapy, G-quadruplex, Telomere targeting agents",
author = "Sara Iachettini and Stevens, {Malcolm F G} and Mark Frigerio and Hummersone, {Marc G.} and Ian Hutchinson and Garner, {Thomas P.} and Searle, {Mark S.} and Wilson, {David W.} and Manoj Munde and Rupesh Nanjunda and Carmen D'Angelo and Pasquale Zizza and Angela Rizzo and Chiara Cingolani and {De Cicco}, Federica and Manuela Porru and Maurizio D'Incalci and Carlo Leonetti and Annamaria Biroccio and Erica Salvati",
year = "2013",
doi = "10.1186/1756-9966-32-68",
language = "English",
volume = "32",
journal = "Journal of Experimental and Clinical Cancer Research",
issn = "0392-9078",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts

AU - Iachettini, Sara

AU - Stevens, Malcolm F G

AU - Frigerio, Mark

AU - Hummersone, Marc G.

AU - Hutchinson, Ian

AU - Garner, Thomas P.

AU - Searle, Mark S.

AU - Wilson, David W.

AU - Munde, Manoj

AU - Nanjunda, Rupesh

AU - D'Angelo, Carmen

AU - Zizza, Pasquale

AU - Rizzo, Angela

AU - Cingolani, Chiara

AU - De Cicco, Federica

AU - Porru, Manuela

AU - D'Incalci, Maurizio

AU - Leonetti, Carlo

AU - Biroccio, Annamaria

AU - Salvati, Erica

PY - 2013

Y1 - 2013

N2 - Quadruplexes DNA are present in telomeric DNA as well as in several cancer-related gene promoters and hence affect gene expression and subsequent biological processes. The conformations of G4 provide selective recognition sites for small molecules and thus these structures have become important drug-design targets for cancer treatment. The DNA G-quadruplex binding pentacyclic acridinium salt RHPS4 (1) has many pharmacological attributes of an ideal telomere-targeting agent but has undesirable off-target liabilities. Notably a cardiovascular effect was evident in a guinea pig model, manifested by a marked and sustained increase in QTcB interval. In accordance with this, significant interaction with the human recombinant β2 adrenergic receptor, and M1, M2 and M3 muscarinic receptors was observed, together with a high inhibition of the hERG tail current tested in a patch clamp assay. Two related pentacyclic structures, the acetylamines (2) and (3), both show a modest interaction with β2 adrenergic receptor, and do not significatively inhibit the hERG tail current while demonstrating potent telomere on-target properties comparing closely with 1. Of the two isomers, the 2-acetyl-aminopentacycle (2) more closely mimics the overall biological profile of 1 and this information will be used to guide further synthetic efforts to identify novel variants of this chemotype, to maximize on-target and minimize off-target activities. Consequently, the improvement of toxicological profile of these compounds could therefore lead to the obtainment of suitable molecules for clinical development offering new pharmacological strategies in cancer treatment.

AB - Quadruplexes DNA are present in telomeric DNA as well as in several cancer-related gene promoters and hence affect gene expression and subsequent biological processes. The conformations of G4 provide selective recognition sites for small molecules and thus these structures have become important drug-design targets for cancer treatment. The DNA G-quadruplex binding pentacyclic acridinium salt RHPS4 (1) has many pharmacological attributes of an ideal telomere-targeting agent but has undesirable off-target liabilities. Notably a cardiovascular effect was evident in a guinea pig model, manifested by a marked and sustained increase in QTcB interval. In accordance with this, significant interaction with the human recombinant β2 adrenergic receptor, and M1, M2 and M3 muscarinic receptors was observed, together with a high inhibition of the hERG tail current tested in a patch clamp assay. Two related pentacyclic structures, the acetylamines (2) and (3), both show a modest interaction with β2 adrenergic receptor, and do not significatively inhibit the hERG tail current while demonstrating potent telomere on-target properties comparing closely with 1. Of the two isomers, the 2-acetyl-aminopentacycle (2) more closely mimics the overall biological profile of 1 and this information will be used to guide further synthetic efforts to identify novel variants of this chemotype, to maximize on-target and minimize off-target activities. Consequently, the improvement of toxicological profile of these compounds could therefore lead to the obtainment of suitable molecules for clinical development offering new pharmacological strategies in cancer treatment.

KW - Anti-cancer therapy

KW - G-quadruplex

KW - Telomere targeting agents

UR - http://www.scopus.com/inward/record.url?scp=84884239677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884239677&partnerID=8YFLogxK

U2 - 10.1186/1756-9966-32-68

DO - 10.1186/1756-9966-32-68

M3 - Article

C2 - 24330541

AN - SCOPUS:84884239677

VL - 32

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

SN - 0392-9078

IS - 1

M1 - 68

ER -